Testosterone Lawsuit Parties File New Joint Status Report in Federal Multidistrict Litigation

Share Article

Bernstein Liebhard LLP is representing a number of testosterone lawsuit plaintiffs in this proceeding who experienced heart attacks, strokes and other cardiovascular complications, allegedly due to their use of prescription testosterone replacement medications.

Free Case Review
Our Firm is representing a number of men who have testosterone lawsuits pending in this proceeding, and we continue to receive inquiries from others who allegedly cardiovascular complications due to these medications.

The parties to hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) have filed a new Joint Status Report in the federal multidistrict litigation currently underway in U.S. District Court, Northern District of Illinois, where Bernstein Liebhard LLP is currently representing a number of clients. According to the March 17th report, document production by a number of defendants is well underway. The report also noted that the parties have taken steps to facilitate coordination of the federal proceeding with various testosterone litigations established in a number of state courts, and that efforts are currently underway to coordinate discovery and case schedules in the federal multidistrict litigation with discovery and case schedules in the state court cases. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is representing a number of men who have testosterone lawsuits pending in this proceeding, and we continue to receive inquiries from others who allegedly experienced heart attacks, strokes and other cardiovascular complications due to prescription medications in this class. We are pleased that discovery is moving forward in these cases, and look forward to notifying our clients of this progress,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing a number of clients who have testosterone lawsuits pending in the federal proceeding, and continues to offer free case reviews to men who may have been harmed by low testosterone treatments.

Testosterone Litigation
Court records indicate that more than 1,170 testosterone treatment lawsuits have been filed in the litigation underway in Illinois. All of the pending complaints accuse the manufacturers of prescription drugs used to treat male hypogonadism (low testosterone) of failing to warn patients and doctors of their potential to cause serious cardiovascular problems. Testosterone lawsuit plaintiffs also allege that the medications were deceptively marketed as treatments for low testosterone related to male aging, when in reality the drugs are only approved to treat hypogonadism caused by disorders of the testicles, pituitary gland, or brain.

According to court documents, testosterone lawsuits have been mounting in U.S. courts since January 2014, when the U.S. Food & Drug Administration (FDA) announced that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* In an update to that announcement issued on March 3, 2015, the FDA announced that it will now require the drugs’ manufacturers to add information to their product labels detailing their potential to increase the risk for heart attacks and strokes. The FDA also expressed concern that these therapies are being used extensively to relieve low testosterone normally associated with aging, and reiterated that the benefits and safety of this use have not been established.

Men who suffered heart attacks, strokes and other serious cardiovascular problems allegedly due to their use of low testosterone therapies may be entitled to take legal action of their own. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website